Pfizer
Headquartered in New York, Washington, D.C., Pfizer is a member of the Fortune 250 operating in the Pharmaceuticals Biotechnology and Life Sciences industry. Albert Bourla DVM Ph.D. serves as CEO/President and Chairman, leading the company’s C-suite executive team and the board of directors. Amongst these teams, the collective leadership is responsible for $269,500 to Republican causes and $1,524,244 to Democratic causes. Under their tenure, Pfizer currently holds a ‘High’ rating.
Company Leadership
Albert Bourla DVM Ph.D.
Albert Bourla has been affiliated Pfizer for more than 30 years, currently serving as the Chief Executive Officer. His other affiliations include the International Federation of Pharmaceutical Manufacturers & Associations, the United States Council for International Business, the Council on Foreign Relations, The Business Council and The Business Roundtable. He holds a Ph.D. in the Biotechnology of Reproduction from the Veterinary School of Aristotle University, a Doctor of Philosophy in Biotechnology of Reproduction from Aristotle University of Thessaloniki, a Doctor of Veterinary Medicine, Honorary Doctorate from American College of Greece, an Honorary Doctorate from the University of Patras, an Honorary Doctorate from Touro University, an Honorary Doctorate from The Technion-Israel Institute of Technology, an Honorary Doctorate from Aristotle University, and Honorary Doctorate from Babson College.
Political Contributions of Leadership
Leadership
Chairman & CEO
Albert Bourla DVM Ph.D.
Chairman & CEO
Shantanu Narayen
Chairman and CEO
James Quincey
Exec VP, General Counsel
Liz Forminard
Chief Corporate Affairs Officer, President
Sally Susman
Chief Business Innovation Officer, Exec VP
Aamir Malik
CFO and Exec VP
Dave Denton
General Counsel, Exec VP
Doug Lankler
Chief Digital and Technology Officer, Exec VP
Lidia Fonseca
Chief Scientific Officer and President, Worldwide Research, Development and Medical of Pfizer Inc.
Mikael Dolsten, MD, Ph.D.
Chief Global Supply Officer, Exec VP
Mike McDermott
Chief People Experience OFficer, Exec VP
Payal Sahni Becher
Chief Compliance, Quality and Risk Officer, Exec VP
Rady Johnson
Chief Commercial Officer, President, Global Biopharmaceuticals Business
Angela Hwang
VP, Chief Corporate Affairs Officer
Yin Becker
Board Member
Joseph J. Echevarria
Board Member
Dan R. Littman, MD, Ph.D.
Board Member
Helen H. Hobbs, MD
Board Member
James C. Smith
Board Member
Ronald E. Blaylock
Board Member
Scott Gottlieb, MD
Board Member
Susan Desmond-Hellmann, MD, MPH
Board Member
Susan Hockfield, Ph.D.
Board Member
Suzanne Nora Johnson